All companies › ALHC

ALHC · Alignment Healthcare, Inc.

Everything on this page is public record — SEC Form 4 filings and congressional disclosures — alongside any INSIDER SCANNER research case for this company.

Open-market buys0
Open-market sells6
Research cases0
Last filing2026-10-06

Insider flow: Selling only — a count of disclosed transactions, not a rating or a recommendation.

Insider transaction timeline

Every reported transaction, positioned by trade date. Purchases sit above the axis, sales below; circle area is proportional to dollar value. No share-price line is drawn — this feed carries transaction prices only, and a price history inferred from them would imply market data the filings do not contain.

Open-market purchase Open-market sale
2026-09-10 — KAO JOHN E · sold 172,600 @ $12.96 2026-09-11 — Maroney Dawn Christine · sold 122,707 @ $12.68 2026-09-11 — KAO JOHN E · sold 385,270 @ $12.68 2026-09-14 — KAO JOHN E · sold 27,400 @ $13.00 2026-09-17 — KONOWIECKI JOSEPH S · sold 23,511 @ $8.61 2026-10-06 — Kim Hyong · sold 32,479 @ $8.30
2026-09-102026-10-06

Insider participation

One row per insider, one cell per reported transaction, shaded by value. Repeat buying and activity clustered in time are visible at a glance.

KAO JOHN E Chief Executive Officer, Director
Maroney Dawn Christine President
KONOWIECKI JOSEPH S EVP, Corporate Affairs, Director
Kim Hyong Chief Medical Officer
Included with a free account

The analysis built on top of these filings

The filings above are public record and stay public here. What an account adds for $ALHC is the reading of them — and for this company, that is what the list below says it is, no more.

  • Transaction timelineThe [{'transaction_date': '2026-10-06', 'insider_name': 'Kim Hyong', 'insider_title': 'Chief Medical Officer', 'transaction_type': 'Open-market sell', 'shares': 32479.0, 'price': 8.3, 'value': 269575.7, 'is_buy': False}, {'transaction_date': '2026-09-17', 'insider_name': 'KONOWIECKI JOSEPH S', 'insider_title': 'EVP, Corporate Affairs, Director', 'transaction_type': 'Open-market sell', 'shares': 23511.0, 'price': 8.61, 'value': 202429.71, 'is_buy': False}, {'transaction_date': '2026-09-14', 'insider_name': 'KAO JOHN E', 'insider_title': 'Chief Executive Officer, Director', 'transaction_type': 'Open-market sell', 'shares': 27400.0, 'price': 13.0, 'value': 356200.0, 'is_buy': False}, {'transaction_date': '2026-09-11', 'insider_name': 'Maroney Dawn Christine', 'insider_title': 'President', 'transaction_type': 'Open-market sell', 'shares': 122707.0, 'price': 12.68, 'value': 1555924.76, 'is_buy': False}, {'transaction_date': '2026-09-11', 'insider_name': 'KAO JOHN E', 'insider_title': 'Chief Executive Officer, Director', 'transaction_type': 'Open-market sell', 'shares': 385270.0, 'price': 12.68, 'value': 4885223.6, 'is_buy': False}, {'transaction_date': '2026-09-10', 'insider_name': 'KAO JOHN E', 'insider_title': 'Chief Executive Officer, Director', 'transaction_type': 'Open-market sell', 'shares': 172600.0, 'price': 12.9574, 'value': 2236447.24, 'is_buy': False}] reported transactions plotted over the window rather than listed, so concentration is visible.

Not available for ALHC today: no reported open-market purchases in this window, so there is no insider cost basis to compute; no research case — nothing here has cleared the scoring threshold. Both appear on this page on their own if that changes.

A free account opens all of it.

Not financial advice. This page reports public filings and past research output. It is not a recommendation to buy or sell, and no price target here is a prediction. Trade at your own risk.